Duke Capital Valuation
Is B34 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of B34 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: B34 (€0.34) is trading below our estimate of fair value (€0.83)
Significantly Below Fair Value: B34 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for B34?
Key metric: As B34 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is B34's PE Ratio? | |
|---|---|
| PE Ratio | 10x |
| Earnings | UK£11.61m |
| Market Cap | UK£115.65m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 5.9x |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | 0.6x |
Price to Earnings Ratio vs Peers
How does B34's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 36.5x | ||
ALG ALBIS Leasing | 13.1x | 9.9% | €58.1m |
GLJ Grenke | 9.5x | 25.2% | €705.1m |
FRS FORIS | 5.5x | n/a | €12.3m |
EBEN aifinyo | 118x | n/a | €13.3m |
B34 Duke Capital | 10x | 18.0% | €115.6m |
Price-To-Earnings vs Peers: B34 is good value based on its Price-To-Earnings Ratio (10x) compared to the peer average (36.5x).
Price to Earnings Ratio vs Industry
How does B34's PE Ratio compare vs other companies in the European Diversified Financial Industry?
| 7 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 7 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: B34 is good value based on its Price-To-Earnings Ratio (10x) compared to the European Diversified Financial industry average (10.8x).
Price to Earnings Ratio vs Fair Ratio
What is B34's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 10x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate B34's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | n/a | €0.58 0% | 7.2% | €0.63 | €0.54 | n/a | 2 |
| Nov ’25 | €0.36 | €0.58 +58.9% | 7.2% | €0.62 | €0.53 | n/a | 2 |
| Oct ’25 | n/a | €0.58 0% | 7.2% | €0.62 | €0.53 | n/a | 2 |
| Sep ’25 | €0.38 | €0.58 +53.0% | 7.2% | €0.62 | €0.53 | n/a | 2 |
| Aug ’25 | n/a | €0.57 0% | 7.2% | €0.61 | €0.53 | n/a | 2 |
| Jul ’25 | n/a | €0.57 0% | 7.2% | €0.61 | €0.53 | n/a | 2 |
| Jun ’25 | n/a | €0.59 0% | 10.0% | €0.65 | €0.53 | n/a | 2 |
| May ’25 | n/a | €0.55 0% | 12.5% | €0.64 | €0.48 | n/a | 3 |
| Apr ’25 | €0.37 | €0.55 +49.9% | 12.5% | €0.64 | €0.48 | n/a | 3 |
| Mar ’25 | n/a | €0.55 0% | 12.5% | €0.64 | €0.48 | n/a | 3 |
| Feb ’25 | n/a | €0.55 0% | 11.0% | €0.63 | €0.50 | n/a | 3 |
| Jan ’25 | n/a | €0.54 0% | 12.5% | €0.63 | €0.47 | n/a | 3 |
| Dec ’24 | n/a | €0.54 0% | 12.5% | €0.63 | €0.47 | n/a | 3 |
| Nov ’24 | n/a | €0.56 0% | 12.2% | €0.63 | €0.50 | €0.36 | 2 |
| Oct ’24 | n/a | €0.56 0% | 12.2% | €0.63 | €0.50 | n/a | 2 |
| Sep ’24 | €0.33 | €0.57 +73.3% | 12.2% | €0.64 | €0.50 | €0.38 | 2 |
| Aug ’24 | n/a | €0.57 0% | 12.2% | €0.64 | €0.50 | n/a | 2 |
| Jul ’24 | n/a | €0.60 0% | 4.9% | €0.63 | €0.57 | n/a | 2 |
| Jun ’24 | n/a | €0.60 0% | 4.9% | €0.63 | €0.57 | n/a | 2 |
| May ’24 | n/a | €0.60 0% | 4.9% | €0.63 | €0.57 | n/a | 2 |
| Apr ’24 | €0.39 | €0.60 +53.9% | 4.9% | €0.63 | €0.57 | €0.37 | 2 |
| Mar ’24 | n/a | €0.60 0% | 4.9% | €0.63 | €0.57 | n/a | 2 |
| Feb ’24 | n/a | €0.60 0% | 4.9% | €0.63 | €0.57 | n/a | 2 |
| Jan ’24 | n/a | €0.60 0% | 4.9% | €0.63 | €0.57 | n/a | 2 |
| Dec ’23 | n/a | €0.60 0% | 2.7% | €0.62 | €0.59 | n/a | 3 |
| Nov ’23 | n/a | €0.60 0% | 2.7% | €0.62 | €0.59 | n/a | 3 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.
Discover undervalued companies
ORIX
JP¥3.8t
Provides diversified financial services in Japan, the United States, Asia, Europe, Australasia, and the Middle East.
OIX
JP¥20.40
7D
1.0%
1Y
22.2%
Exor
€20.6b
Engages in the luxury goods, automotive, agricultural and construction equipment, commercial vehicles, and professional football businesses worldwide.
EYX
€95.55
7D
2.9%
1Y
8.8%
Mutares SE KGaA
€484.6m
A private equity firm specializing in investments in secondary direct, special situations, bridge financing, recapitalization, distressed/vulture, management succession, reorganization, carve-outs, turnarounds, spin-offs and re-funding.
MUX
€22.40
7D
1.1%
1Y
-28.9%